NCT01318551View on ClinicalTrials.gov

Single Dose Group Stratified Study in Renal Impaired and Healthy Aged and Gender Matched Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 16, 2011

Primary Completion Date

September 5, 2013

Study Completion Date

August 14, 2014

Conditions
Anemia
Interventions
DRUG

BAY85-3934

single dose, 20 mg

DRUG

BAY85-3934

single dose, 40 mg (optional)

DRUG

BAY85-3934

single dose, 80 mg (optional)

Trial Locations (1)

24105

Kiel

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY